DRAXIS to Present at the CIBC World Markets 14th Annual Healthcare Conference.Business Editors/Health/Medical Writers MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nov. 6, 2003 DRAXIS Health Inc. (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension :DAX) (Nasdaq:DRAX) announced today that Dr. Martin Barkin, President and Chief Executive Officer, will participate in the CIBC World Markets CIBC World Markets is the investment banking division of the Canadian Imperial Bank of Commerce. It helps governments, large companies, and other large institutions obtain capital and credit and is a primary dealer in U.S. Treasury securities. Fourteenth Annual Healthcare Conference, which is being held in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , NY from November 10 - 12, 2003 at the Plaza Hotel The Plaza Hotel in New York City is a landmark 19-story luxury hotel with a height of 250 feet (76 m) and length of 400 feet that (122 m) occupies the west side of Grand Army Plaza, from which it derives its name, and extends along Central Park South in Manhattan. . Dr. Barkin is scheduled to present on Tuesday, November 11 at 3:30 p.m. ET. Investors can listen to a live audio webcast of the DRAXIS presentation at www.draxis.com or by visiting the Veracast Web site at http://www.veracast.com/webcasts/cibcwm/healthcare03/64314484.cfm. The webcast will automatically be archived approximately three hours after the live event and will be available for 30 days, through Friday, December 12, 2003, at 5 p.m. PT. About DRAXIS Health Inc. DRAXIS Health Inc. (www.draxis.com) is a specialty pharmaceutical company involved in the development, production, marketing and distribution of therapeutic and diagnostic radiopharmaceuticals through DRAXIMAGE Inc. and in the provision of pharmaceutical contract manufacturing services, specializing in liquid and freeze-dried injectables and other sterile sterile /ster·ile/ (ster´il) 1. unable to produce offspring. 2. aseptic. ster·ile adj. 1. Not producing or incapable of producing offspring. 2. products, through DRAXIS Pharma Inc. DRAXIS Health employs over 400 staff and reported sales in 2002 in excess of US$38 million. Except for historical information, this news release contains certain forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 as amended, which involve risk and uncertainties that may cause actual results to differ materially from the statements made. Such factors include, but are not limited to, timely regulatory approval of the Company's products, the ability to obtain and enforce effective patents, the establishment and maintenance of new corporate alliances, compliance with appropriate governmental regulations, and other risks detailed from time-to-time in the Company's filings with the US Securities and Exchange Commission and Canadian securities authorities. The Company does not undertake to update such forward-looking statements to reflect new information, later events or developments. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion